MTS assay showed that the treatment of different cells with 25 uM PRIMA-1Met for 12 h or 24 h led to similar suppression of cell growth, indicating that CRC cells with different TP53 status were generally sensitive to PRIMA-1Met (Figure 1B). Here, TP53 is linked to colorectal carcinoma.